Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hider

Showing results (281-290 of 688) with videos related to

Pageof 69
Sort By:
Journal of Autism and Developmental Disorders|September 7, 2007
Offending behaviour in adults with Asperger syndromeDavid Allen, Carys Evans, Andrew Hider, et al.
Biochemical Society Transactions|November 22, 2008
Iron chelation as a potential therapy for neurodegenerative diseaseRobert C Hider, Yongmin Ma, Francisco Molina-Holgado, et al.
European Journal of Biochemistry|June 1, 1987
Cobra cardiotoxins. Purification, effects on skeletal muscle and structure/activity relationships [published errtum appears in Eur J Biochem 1988 Feb 1;171(3):727]S J Hodges, A S Agbaji, A L Harvey, et al.
British Journal of Haematology|December 31, 1997
Non-transferrin-bound iron induced by myeloablative chemotherapyS J Bradley, I Gosriwitana, S Srichairatanakool, et al.
Rheumatology Advances in Practice|January 6, 2022
Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort StudyBalamrit Singh Sokhal, Samantha L Hider, Zoe Paskins, et al.
BMC Musculoskeletal Disorders|May 12, 2019
Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohortSamantha L Hider, Kika Konstantinou, Elaine M Hay, et al.
Blood|July 15, 1996
Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapyJ B Porter, R D Abeysinghe, L Marshall, et al.
Journal of Hepatology|June 14, 2000
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based methodO Loréal, I Gosriwatana, D Guyader, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the ratR Choudhury, R O Epemolu, B L Rai, et al.
ACS Chemical Neuroscience|November 4, 2020
Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson's DiseaseYingying Sun, A Ninh Pham, Robert C Hider, et al.
Pageof 69

Showing results (281-290 of 688) with videos related to

Sort By:
Pageof 69
Journal of Autism and Developmental Disorders|September 7, 2007
Offending behaviour in adults with Asperger syndromeDavid Allen, Carys Evans, Andrew Hider, et al.
Biochemical Society Transactions|November 22, 2008
Iron chelation as a potential therapy for neurodegenerative diseaseRobert C Hider, Yongmin Ma, Francisco Molina-Holgado, et al.
European Journal of Biochemistry|June 1, 1987
Cobra cardiotoxins. Purification, effects on skeletal muscle and structure/activity relationships [published errtum appears in Eur J Biochem 1988 Feb 1;171(3):727]S J Hodges, A S Agbaji, A L Harvey, et al.
British Journal of Haematology|December 31, 1997
Non-transferrin-bound iron induced by myeloablative chemotherapyS J Bradley, I Gosriwitana, S Srichairatanakool, et al.
Rheumatology Advances in Practice|January 6, 2022
Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort StudyBalamrit Singh Sokhal, Samantha L Hider, Zoe Paskins, et al.
BMC Musculoskeletal Disorders|May 12, 2019
Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohortSamantha L Hider, Kika Konstantinou, Elaine M Hay, et al.
Blood|July 15, 1996
Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapyJ B Porter, R D Abeysinghe, L Marshall, et al.
Journal of Hepatology|June 14, 2000
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based methodO Loréal, I Gosriwatana, D Guyader, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1997
Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the ratR Choudhury, R O Epemolu, B L Rai, et al.
ACS Chemical Neuroscience|November 4, 2020
Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson's DiseaseYingying Sun, A Ninh Pham, Robert C Hider, et al.
Pageof 69